CAMBREX CORP·4

Aug 7, 5:53 PM ET

Cavanagh Shawn 4

4 · CAMBREX CORP · Filed Aug 7, 2018

Insider Transaction Report

Form 4
Period: 2018-08-06
Cavanagh Shawn
Executive Vice President & COO
Transactions
  • Exercise/Conversion

    Common Stock

    2018-08-06$16.91/sh+10,000$169,05027,658 total
  • Exercise/Conversion

    Common Stock

    2018-08-06$17.81/sh+10,000$178,10037,658 total
  • Exercise/Conversion

    Common Stock

    2018-08-06$40.65/sh+399$16,21955,557 total
  • Sale

    Common Stock

    2018-08-06$63.16/sh8,744$552,27117,658 total
  • Exercise/Conversion

    Common Stock

    2018-08-06$41.35/sh+17,500$723,71355,158 total
  • Sale

    Common Stock

    2018-08-06$62.11/sh29,155$1,810,81726,402 total
  • Exercise/Conversion

    Common Stock

    2018-08-07$40.65/sh+8,351$339,46826,009 total
  • Sale

    Common Stock

    2018-08-07$62.89/sh8,351$525,19417,658 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-06+10,0000 total
    Exercise: $16.91Exp: 2020-10-28Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-06+10,00010,000 total
    Exercise: $17.81Exp: 2021-10-22Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-06+17,50017,500 total
    Exercise: $41.35Exp: 2022-10-21Common Stock (17,500 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-06+39934,601 total
    Exercise: $40.65Exp: 2023-10-26Common Stock (399 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-07+8,35126,250 total
    Exercise: $40.65Exp: 2023-10-26Common Stock (8,351 underlying)
Footnotes (6)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.65 to $62.65 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.70 to $63.50 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.
  • [F3]The option representing a right to purchase 40,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted
  • [F4]The option representing a right to purchase 40,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted.
  • [F5]The option representing a right to purchase 35,000 shares became exercisable in four equal installments beginning October 21, 2016, which was the first anniversary of the date on which the option was granted.
  • [F6]The option representing a right to purchase 35,000 shares became exercisable in four equal installments beginning October 26, 2017, which was the first anniversary of the date on which the option was granted.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION